Minimally invasive, implantable endovascular neuromodulation devices
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
330
NCT02332005
12-Month Efficacy and Safety of Diepalrestat in Adults With Diabetic Peripheral Neuropathy, a DB, Placebo-Controlled Study
Phase: Phase 2/3
Role: Lead Sponsor
Start: Nov 30, 2014
Completion: Nov 30, 2017
Loading map...